<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02619539</url>
  </required_header>
  <id_info>
    <org_study_id>KAPIM-1</org_study_id>
    <nct_id>NCT02619539</nct_id>
  </id_info>
  <brief_title>Shock Index To DEtect Low Plasma Fibrinogen In Trauma (SIDE)</brief_title>
  <acronym>SIDE</acronym>
  <official_title>Shock Index To DEtect Low Plasma Fibrinogen In Trauma (SIDE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masaryk Hospital Krajská zdravotní a.s.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Masaryk Hospital Krajská zdravotní a.s.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Shock-index is potentially an easy tool to estimate the risk of hypofibrinogenemia without
      the need to perform other potentially time consuming investigations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypofibrinogenemia is common in severe trauma and below the threshold of 2.3 g/l is
      associated with increased mortality. Although guidelines for management of the trauma induced
      coagulopathy does not recommend any specific timing of fibrinogen substitution, several
      papers suggest that early substitution might be associated with improved outcome. Laboratory
      measurement of plasma fibrinogen level, thromboelastometry and/or its estimation based on
      base excess, hemoglobin level, Injury Severity Score or combinations require diagnostic
      procedures that are associated with with a certain time delay and prolongs the time to
      fibrinogen substitution.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">February 28, 2017</completion_date>
  <primary_completion_date type="Actual">February 28, 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Proportion of subjects that have plasma fibrinogen &lt;2.3 g.l-1 on admission among those with shock-index &gt;1.</measure>
    <time_frame>On admission</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">280</enrollment>
  <condition>Trauma, Multiple</condition>
  <arm_group>
    <arm_group_label>Trauma patients</arm_group_label>
    <description>All patients having / suspected to have severe trauma injuries admitted to participating centers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>plasma fibrinogen measurement</intervention_name>
    <description>plasma fibrinogen measurement</description>
    <arm_group_label>Trauma patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient having / suspected to have severe trauma admitted to participating centres.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient having / suspected to have severe trauma transported to participating centers
             by cooperating Emergency Medical System organizations

        Exclusion Criteria:

          -  possible alterations of plasma fibrinogen level in the time of trauma (inflammatory
             disease, malignant disease, pregnancy)

          -  administration of fibrinogen containing products (fresh frozen plasma, fibrinogen
             concentrate, cryoprecipitate) before sampling blood for fibrinogen level

          -  circumstances possibly interfering with plasma fibrinogen level measurement (prior the
             administration of hydroxyethylstarches)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josef Skola, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Masaryk Hospital Usti nad Labem</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital in Plzen</name>
      <address>
        <city>Plzen</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Masaryk Hospital in Usti nad Labem</name>
      <address>
        <city>Usti nad Labem</city>
        <zip>40001</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <reference>
    <citation>Hagemo JS, Stanworth S, Juffermans NP, Brohi K, Cohen M, Johansson PI, Røislien J, Eken T, Næss PA, Gaarder C. Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicentre observational study. Crit Care. 2014 Mar 26;18(2):R52. doi: 10.1186/cc13798.</citation>
    <PMID>24666991</PMID>
  </reference>
  <reference>
    <citation>Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care. 2013 Apr 19;17(2):R76. doi: 10.1186/cc12685. Review.</citation>
    <PMID>23601765</PMID>
  </reference>
  <reference>
    <citation>Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg. 2012 Feb;114(2):261-74. doi: 10.1213/ANE.0b013e31822e1853. Epub 2011 Sep 29. Review.</citation>
    <PMID>21965371</PMID>
  </reference>
  <reference>
    <citation>Schöchl H, Maegele M, Solomon C, Görlinger K, Voelckel W. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med. 2012 Feb 24;20:15. doi: 10.1186/1757-7241-20-15. Review.</citation>
    <PMID>22364525</PMID>
  </reference>
  <reference>
    <citation>Schlimp CJ, Voelckel W, Inaba K, Maegele M, Ponschab M, Schöchl H. Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission. Crit Care. 2013 Jul 12;17(4):R137. doi: 10.1186/cc12816.</citation>
    <PMID>23849249</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2015</study_first_submitted>
  <study_first_submitted_qc>November 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2015</study_first_posted>
  <last_update_submitted>March 22, 2017</last_update_submitted>
  <last_update_submitted_qc>March 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Masaryk Hospital Krajská zdravotní a.s.</investigator_affiliation>
    <investigator_full_name>Josef Skola</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Multiple Trauma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

